{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:51Z","timestamp":1793724291644,"version":"4.6.1"},"reference-count":113,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1080\/14737175.2022.2029703","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T17:02:28Z","timestamp":1643216548000},"page":"101-114","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":65,"title":["Current and emerging treatment modalities for spinocerebellar ataxias"],"prefix":"10.1080","volume":"22","author":[{"given":"Shaila D.","family":"Ghanekar","sequence":"first","affiliation":[{"name":"University of South Florida (USF) Department of Neurology, USF Ataxia Research Center, Tampa, Florida, USA"},{"name":"Department of Neurology, James A Haley Veteran\u2019s Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Han","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Columbia University, New York, New York, USA"},{"name":"Department of Neurology, Initiative for Columbia Ataxia and Tremor, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Staffetti","sequence":"additional","affiliation":[{"name":"University of South Florida (USF) Department of Neurology, USF Ataxia Research Center, Tampa, Florida, USA"},{"name":"Department of Neurology, James A Haley Veteran\u2019s Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A","family":"Zesiewicz","sequence":"additional","affiliation":[{"name":"University of South Florida (USF) Department of Neurology, USF Ataxia Research Center, Tampa, Florida, USA"},{"name":"Department of Neurology, James A Haley Veteran\u2019s Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1097\/WNO0b013e3181b416de"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0051-6"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-010-0183-8"},{"issue":"2","key":"cit0004","first-page":"57","volume":"2","author":"Almeida-Silva UC","year":"2013","journal-title":"Am J Neurodegener Dis"},{"key":"cit0005","first-page":"1","volume-title":"GeneReviews\u00ae","author":"Bird TD","year":"1993"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0074-3"},{"key":"cit0007","first-page":"143","volume-title":"Handbook of Clinical Neurology","volume":"155","author":"Soong BW","year":"2018"},{"key":"cit0008","volume-title":"UpToDate","author":"Opal P","year":"2021"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl081"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-00696-y"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.1.2.125.61044"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9076-4"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2018.02.005"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117417"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d31e23"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00201-X"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420216"},{"key":"cit0018","unstructured":"Riluzole. In:\n                      LiverTox: Clinical and Research Information on Drug-Induced Liver Injury\n                      . National Institute of Diabetes and Digestive and Kidney Diseases; 2012. [cited 2021 Aug 17]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548919\/"},{"key":"cit0019","unstructured":"Biohaven Pharmaceuticals, Inc.\n                      A Phase III, Long-Term, Randomized, Double-Blind, Placebo-Controlled Trial of Troriluzole in Adult Subjects With Spinocerebellar Ataxia\n                      . clinicaltrials.gov; 2021. [cited 2021 Aug 5]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03701399"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.527"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2012.07.013"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00913.2015"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2789-11.2011"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-010-0182-9"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1113\/JP271897"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.07.020"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14366"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2018.05.009"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170529104000"},{"issue":"4","key":"cit0030","first-page":"1050","volume":"16","author":"Egorova PA","year":"2019","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010216"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2018.02.017"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28355"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2018.06.006"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(83)90008-4"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322168"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005055"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173271"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.01.023"},{"key":"cit0040","first-page":"1","volume-title":"StatPearls","author":"Singh D","year":"2021"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318247cc7a"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-013-0531-6"},{"key":"cit0043","first-page":"73","author":"Wecker L","year":"2013","journal-title":"Neuropharmacology"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.04.032"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)65674-7"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540340074015"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.04.019"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.03.005"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.346"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-019-01016-6"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.576579"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25803"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7551-0"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1097\/JNN.0000000000000468"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12341"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.61.3.259"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812441999"},{"key":"cit0058","unstructured":"Pacheco LP, Thakur N Amantadine therapy for ataxia management in patients with spinocerebellar ataxia type 7. MDS Abstracts. [cited 2021 Aug 18]. Available from: https:\/\/www.mdsabstracts.org\/abstract\/amantadine-therapy-for-ataxia-management-in-patients-with-spinocerebellar-ataxia-type-7\/"},{"key":"cit0059","first-page":"1","volume-title":"StatPearls","author":"Farzam K","year":"2021"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.12.1259"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.4.565"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.00299.x"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-015-1530-4"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093063"},{"key":"cit0065","unstructured":"Ltd BP. Bioblast announces phase 2a results of trehalose in patients with spinocerebellar ataxia type 3 (SCA3). GlobeNewswire News Room. Published January 18, 2017. [cited 2021 Nov 8]. Available from: https:\/\/www.globenewswire.com\/news-release\/2017\/01\/18\/906630\/32455\/en\/Bioblast-Announces-Phase-2a-Results-of-Trehalose-in-Patients-with-Spinocerebellar-Ataxia-Type-3-SCA3.html"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.12.007"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1177\/1545968311425918"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1177\/1545968314522350"},{"key":"cit0069","first-page":"37","author":"Winser S","year":"2014","journal-title":"Disabil Rehabil"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/583507"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-013-0514-7"},{"key":"cit0072","unstructured":"Commissioner O of the. FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder. FDA. Published March 24, 2020. [cited 2021 Aug 15]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-permits-marketing-transcranial-magnetic-stimulation-treatment-obsessive-compulsive-disorder"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.1.124"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00073"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.09.001"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-020-01181-z"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-013-0524-5"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26356"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006210"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061948"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00808.2016"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1186\/s40673-017-0072-8"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1379-2"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-018-0271-1"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(02)00009-6"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02318.x"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26088"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00902"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2017.0209"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2015.12.031"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2015.12.028"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2015.12.048"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212198"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-070918-050501"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900907"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1038\/nature22044"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.07.030"},{"key":"cit0098","first-page":"7","author":"Moore L","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8677"},{"key":"cit0100","unstructured":"Biogen.\n                      A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB105 Administered Intrathecally to Adults With Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in the Ataxin-2 Gene\n                      . clinicaltrials.gov; 2021. [cited 2021 Nov 7]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04494256. *This is the first clinical trial to employ ASOs in the treatment of a neurodegenerative disease."},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10020119"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190403"},{"issue":"6","key":"cit0103","first-page":"387","volume":"57","author":"Schwartz M","year":"2021","journal-title":"Drugs Today Barc Spain 1998"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198"},{"issue":"2","key":"cit0105","volume":"4","author":"Bushart DD","year":"2016","journal-title":"Ann Transl Med"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.031930"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-200438"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64674"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.0.CO;2-M"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28749"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911803"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2018.06.011"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa184"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2022.2029703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T02:27:55Z","timestamp":1646015275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2022.2029703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"alternative-id":["10.1080\/14737175.2022.2029703"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2022.2029703","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}